Surgery Partners (SGRY) Set to Announce Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY) is set to post its quarterly earnings results before the market opens on Tuesday, November 12th. Analysts expect Surgery Partners to post earnings of $0.21 per share for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, August 6th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The firm had revenue of $762.10 million for the quarter, compared to analyst estimates of $735.94 million. During the same quarter last year, the business earned $0.25 earnings per share. Surgery Partners’s revenue was up 14.2% compared to the same quarter last year. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Stock Performance

Shares of SGRY stock opened at $29.22 on Tuesday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69. The company’s fifty day simple moving average is $31.20 and its 200-day simple moving average is $28.26. Surgery Partners has a 52 week low of $22.25 and a 52 week high of $36.92.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Citigroup reduced their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research report on Wednesday, August 7th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a research note on Wednesday, August 7th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research report on Friday, October 4th. Royal Bank of Canada restated an “outperform” rating and issued a $49.00 price objective on shares of Surgery Partners in a report on Wednesday, August 7th. Finally, Macquarie restated an “outperform” rating and set a $35.00 target price on shares of Surgery Partners in a report on Monday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Surgery Partners has a consensus rating of “Moderate Buy” and a consensus price target of $40.13.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.